Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Here are Prakash Diwan's top trading ideas

      In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, Prakash Diwan of Altamount Capital Management shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Buy, sell, hold: 7 stocks to watch out for your portfolio

      Morgan Stanley is underweight on the stock, with a target price at Rs 1,372. Key positive surprise was better-than-expected realisation but better realisation was offset by higher per tonne cost, the research firm says.

    • Exit Glenmark Pharma at Rs 950: Vijay Chopra

      According to Vijay Chopra of enochventures.com, one may exit Glenmark Pharma at Rs 950.

    • Go long in Indiabulls Housing, Dr Reddy's Labs: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one can go long in Indiabulls Housing Finance and Dr Reddy's Laboratories.

    • Hold Dr Reddy‘s Laboratories: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that one may hold Dr Reddy's Laboratories.

    • Hold Dr Reddy‘s Laboratories: Avinash Gorakshakar

      Avinash Gorakshakar, Market Expert is of the view that one may hold Dr Reddy‘s Laboratories.

    • Buy Tata Elxsi, Vedanta; sell Dr Reddy's Labs: Sandeep Wagle

      According to Sandeep Wagle of powermywealth.com, one can buy Tata Elxsi and Vedanta and sell Dr Reddy's Laboratories.

    • Buy HT Media, Cummins; sell Century Tex: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one may buy HT Media and Cummins India and advises selling Century Textiles and Dr Reddy's Laboratories.

    • Buy, sell, hold: 12 stocks to watch out as earnings start

      JP Morgan stays neutral on TCS with target of Rs 2450 per share as company has shown weakness in revenue growth trajectory in recent quarters.

    • Top buzzing stocks to trade on January 12

      Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today -- Idea Cellular, Sun Pharma, DRL, Lupin, Aurobindo Pharma , Glenmark, Natco Pharma, Alkem Labs, Ajanta Pharma, Strides Shasun, Biocon, Cipla, Cyient, MMTC and Power Grid.

    • Buy, sell, hold: 11 stocks that analysts are watching out today

      Nomura has a buy ratings on Dr Reddy‘s, Glenmark, Alkem, Cadila and Jubilant Life. It says Teva‘s 2017 guidanceis lower than what was presented in 2016-2020 prelim outlook and implies a shortfall of USD 1.5-2 billion in EBITDA. Teva expects mid-single digit price erosion in the base US business.

    • Buy, sell, hold: 9 pharma & media stocks that you may focus

      Citi upgrades Sun TV to buy and Zee Entertainment to neutral. It prefers Dish TV at current valuations, retaining buy call on the stock.

    • Buy, sell, hold: 6 stocks to watch out on 2016 last trading day

      Nomura is neutral on Lupin and Torrent. It has a buy rating on Dr Reddy‘s and Cadila. It says trailing three-month sales declined sequentially for Torrent, Sun Pharma and Glenmark. Torrent‘s sales were down on account of price erosion in gAbilify. Sun‘s T3M sales declined QoQ due to price erosion and market share loss in gGleevec.

    • Buy Maruti, Dr Reddy's, Ambuja Cements; sell DLF: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com suggests buying Maruti Suzuki, Dr Reddy's Labs and Ambuja Cements and advises selling DLF.

    • Buy Dr Reddy's Laboratories closer to Rs 2800: Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas advises buying Dr Reddy's Laboratories closer to Rs 2800.

    • Pick UltraTech Cement, SBI, Dr Reddy's Labs: Sanjiv Bhasin

      Sanjiv Bhasin of IIFL is of the view that one can pick UltraTech Cement, State Bank of India and Dr Reddy's Labs.

    • Buy Adani Ports, Tata Elxsi; sell Tata Steel: Ashwani Gujral

      Ashwani Gujral, Fund Manager at ashwanigujral.com recommends buying Adani Ports and Tata Elxsi and advises selling Tata Steel.

    • Buy Infosys above Rs 985, sell DCB Bank: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one can buy Infosys above Rs 985 and sell DCB Bank.

    • Buy Dr Reddy's Laboratories, says Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, one can buy Dr Reddy's Laboratories with target of Rs 3310.

    • Positive on Dr Reddy's Labs, buy HCL Tech 800 Call: Amit Gupta

      Amit Gupta, Head - Derivatives at at ICICIdirect has a positive view on Dr Reddy's Labs and recommends buying HCL Tech 800 Call.

    • Buy Dr Reddy's Laboratories, says Rajat Bose

      Rajat Bose of rajatkbose.com advises buying Dr Reddy's Laboratories.

    • Buy Dr Reddy's Lab, DHFL, Power Finance Corp: Sandeep Wagle

      According to Sandeep Wagle of powermywealth.com, one may buy Power Finance Corporation, Dr Reddy's Laboratories and Dewan Housing Finance Corporation.

    • Buy SBI, PNB, Dr Reddy's; sell ACC, Tata Motors: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying State Bank of India, Punjab National Bank and Dr Reddy's Laboratories and advises selling ACC and Tata Motors.

    • Buy SBI, Dr Reddy's Labs, Torrent Pharma, Bharat Forge: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying SBI, Karnataka Bank, Dr Reddy's Laboratories, Torrent Pharma and Bharat Forge.

    • Cement, pharma and banks look attractive: Tulsian

      The demonetization of Rs 500 and rs 1,000 notes couple with Donald Trump‘s victory in US presidential elections make sectors like pharma, cement, NBFC and banks a good bet, said SP Tulsian of SP Tulsian.com.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347